Drug Type Small molecule drug |
Synonyms |
Mechanism DENV NS5 polymerase inhibitors(DENV NS5 polymerase inhibitors), RdRp inhibitors(RNA-directed RNA polymerase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dengue | Preclinical | US | 23 Nov 2020 |